Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 273-9400

Ginger Clark, MD, MS : Research

Gastroenterologist, Transplant Hepatologist

Photo of Ginger Clark
(352) 273-9400 MyUFHealth

Research at a glance

Top areas of exploration

  • Liver Cirrhosis , 8 publications
  • Hepatitis C , 8 publications
  • alpha 1-Antitrypsin Deficiency , 6 publications
  • Antiviral Agents , 6 publications

Research activity

41 publications

1,088 citations

Why is this important?

Active clinical trials

TAK-999-3003

The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin (Z-AAT) protein. People who are currently taking part in or have completed previous…

Investigator
Ginger Clark
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Takeda TAK-999-3001

The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening in the liver, to get information on how fazirsiran affects the body…

Investigator
Ginger Clark
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All
NN9931-4553 ESSENCE

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine * which…

Investigator
Ginger Clark
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

41 publications

2024

Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease.

Alimentary pharmacology & therapeutics

PubMed • Publisher's site

2021

Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.

Journal of hepatology

PubMed • Publisher's site

2021

Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens.

PloS one

PubMed • Publisher's site

2019

Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD.

Journal of critical care

PubMed • Publisher's site